direct,indirect,issuer_cik,issuer_name,isDirector,isOfficer,isTenPercentOwner,isOther,date,name,accession,officerTitle,predicted_gender,total_stock
0.0,0.0,1600132,"bellerophon therapeutics, inc.",0,1,0.0,0.0,20150219,abrams david,110465915012179,Treasurer,male,
0.0,0.0,1600132,"bellerophon therapeutics, inc.",0,1,0.0,0.0,20150219,heyrman reinilde,110465915012180,Chief Clinical Dev. Officer,male,
0.0,0.0,1600132,"bellerophon therapeutics, inc.",0,1,0.0,0.0,20150219,meglasson martin,110465915012181,Chief Scientific Officer,male,
0.0,0.0,1600132,"bellerophon therapeutics, inc.",0,1,0.0,0.0,20150219,naidu manesh,110465915012182,Chief Business Officer,male,
4859885.0,0.0,1600132,"bellerophon therapeutics, inc.",1,0,1.0,0.0,20150223,weinstein adam,110465915013149,,male,
4859885.0,0.0,1600132,"bellerophon therapeutics, inc.",1,0,1.0,0.0,20150223,holt matthew s.,110465915013148,,male,
1629804.0,0.0,1600132,"bellerophon therapeutics, inc.",0,0,1.0,0.0,20150223,"linde north america, inc.",110465915013147,,male,
1629804.0,0.0,1600132,"bellerophon therapeutics, inc.",1,0,1.0,0.0,20150223,luehring jens,110465915013146,,male,
965660.0,0.0,1600132,"bellerophon therapeutics, inc.",1,0,1.0,0.0,20150223,nelsen robert,110465915013151,,male,
9483.0,0.0,1600132,"bellerophon therapeutics, inc.",0,1,0.0,0.0,20150223,heyrman reinilde,110465915013143,Chief Clinical Dev. Officer,male,
18386.0,0.0,1600132,"bellerophon therapeutics, inc.",0,1,0.0,0.0,20150223,meglasson martin,110465915013142,Chief Scientific Officer,male,
11319.0,0.0,1600132,"bellerophon therapeutics, inc.",0,1,0.0,0.0,20150223,naidu manesh,110465915013141,Chief Business Officer,male,
20867.0,0.0,1600132,"bellerophon therapeutics, inc.",1,1,0.0,0.0,20150223,peacock jonathan m,110465915013140,President and CEO,male,
128898.0,0.0,1600132,"bellerophon therapeutics, inc.",1,0,0.0,0.0,20150223,tasse daniel,110465915013145,,male,
0.0,0.0,1600132,"bellerophon therapeutics, inc.",0,1,0.0,0.0,20150316,abrams david,117911015004964,Treasurer,male,
0.0,0.0,1600132,"bellerophon therapeutics, inc.",0,1,0.0,0.0,20150316,meglasson martin,117911015004962,Chief Scientific Officer,male,
0.0,0.0,1600132,"bellerophon therapeutics, inc.",0,1,0.0,0.0,20150316,heyrman reinilde,117911015004963,Chief Clinical Dev. Officer,male,
0.0,0.0,1600132,"bellerophon therapeutics, inc.",1,1,0.0,0.0,20150316,peacock jonathan m,117911015004956,President and CEO,male,
0.0,0.0,1600132,"bellerophon therapeutics, inc.",0,1,0.0,0.0,20150316,naidu manesh,117911015004958,Chief Business Officer,male,
0.0,0.0,1600132,"bellerophon therapeutics, inc.",1,0,0.0,0.0,20150514,bruder scott p,117911015007859,,male,12905392.0
0.0,0.0,1600132,"bellerophon therapeutics, inc.",1,0,0.0,0.0,20150514,huennekens r scott,117911015007860,,male,12905392.0
0.0,0.0,1600132,"bellerophon therapeutics, inc.",0,1,0.0,0.0,20150520,fernandes peter,117911015008249,Chief Regulatory Officer,male,12905392.0
26427.0,0.0,1600132,"bellerophon therapeutics, inc.",1,1,0.0,0.0,20150522,peacock jonathan m,117911015008413,President and CEO,male,12905392.0
19098.0,0.0,1600132,"bellerophon therapeutics, inc.",0,1,0.0,0.0,20150522,meglasson martin,117911015008414,Chief Scientific Officer,male,12905392.0
0.0,0.0,1600132,"bellerophon therapeutics, inc.",1,0,0.0,0.0,20150701,amin naseem,117911015010601,,male,12911905.0
0.0,0.0,1600132,"bellerophon therapeutics, inc.",0,1,0.0,0.0,20150713,agrawal amit,117911015011121,Chief Operating Officer,male,12911905.0
31427.0,0.0,1600132,"bellerophon therapeutics, inc.",1,1,0.0,0.0,20150820,peacock jonathan m,117911015012431,President and CEO,male,12911905.0
